As of January 2026 Lyell Immunopharma has a market cap of $0.65 Billion USD. This makes Lyell Immunopharma the world's 6719th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 1st, 2026 the market cap of Lyell Immunopharma was reported to be: